N,N′-二(芳磺酰)亚磺酰胺-S-(2-苯并咪唑基)类化合物的合成

本文报道了新化合物N,N＇—二(芳磺酰)亚磺酰胺—S—(2—苯并咪唑基)钠(a～e)以及N,N＇—二(芳磺酰)亚磺酰胺—S—(2—苯并咪唑基)(f～i)的合成。通过在感光乳剂中的应用,我们发现a,b和c具有超增感作用,它们分别使卤化银乳剂的感光度提高62％,22％和45％。 钠—N—氯芳磺酰亚胺化合物既是一类精细化工产品,又是一类重要的反应中间体。由它们     

N,N′-二(芳磺酰)亚磺酰胺-S-(2-苯并咪唑)钠作为稳定剂的研究

研究了新型感光稳定剂Ｎ，Ｎ′－二（芳磺酰）亚磺酰胺－Ｓ－（２－苯并咪唑）钠（芳磺酰基为苯磺酰，对甲苯磺酰，对氯苯磺酰）与增感染料在实用照相乳剂中的超增感与防灰雾作用。实验结果表明，在多种不同组分的卤化银乳剂中，可提高感光度，抑制灰雾或对感光度和灰雾具有一致的理想效果。     

N,N‘—二（芳磺酰）亚磺酰胺—S—（2—苯并咪唑）钠作为稳定的研究

研究了新型感光稳定剂Ｎ，Ｎ’－二（芳磺酰）亚磺酰胺－Ｓ－（２－苯并咪唑）钠（芳磺酰基为苯磺酰，对甲苯磺酰，对氯苯磺酰）与增感染料在实用照相乳剂虽的超增感与防雾作用。     

N'-(5-芳基-1,3,4(口恶)二唑-2-基)-N-(邻苯磺酰甲酰亚胺乙酰基)硫脲的合成及抑菌活性

将邻苯甲酰磺酰亚胺、1.3,4-(口恶)二唑2个杂环同时引入到酰基硫脲中,合成了12种新的N'-(5-芳基-1,3,4.(口恶)二唑-2-基)-N-(邻苯磺酰甲酰亚胺乙酰基)硫脲化合物,化合物的结构均经元素分析、1H NMR和IR 等测试技术得以确证.抑菌法生物活性测试结果表明,大部分化合物对黄瓜灰霉病菌、油菜菌核病菌抑制效果很好,特别是化合物5b和5l对5种病菌抑制率均在87%以上,有的病菌抑制率达到100%.     

4-芳氧乙(丙)酰氨基苯磺酰胺的合成与除草活性

芳氧羧酸;4-芳氧乙(丙)酰氨基苯磺酰胺的合成与除草活性     

N-(取代嘧啶-2'-基)-2-三氟乙酰氨基苯磺酰脲的合成及除草活性

磺酰脲类除草剂是近 2 0年来开发出的超高效、广谱、低毒和高选择性除草剂 .在已研究的磺酰脲分子中 ,芳环的邻位取代基多为酯基、卤素、取代烷氧基、三氟甲基等 [1,2 ] ,而邻位取代基为酰胺基的甚少 .为寻找高活性的磺酰脲化合物 ,本文将活性基团三氟乙酰氨基引入磺酰脲分子中 ,合成了 1 0种 N - (取代嘧啶 - 2 -基 ) - 2 -三氟乙酰氨基苯磺酰脲 (其中 9种为新化合物 ,4b～ 4j) ,并改进了实验方法 ,使产率明显提高 .同时还测定了它们的除草活性 ,其中一些化合物具有良好的活性 .合成路线如下 :　　 X- 4数字显示显微熔点仪 ,温度计未校正…     

N,N'-二(2-羟苄基)取代咪唑烷的合成、表征及抑菌活性

利用生物活性叠加原理,将"邻羟苯基"和"咪唑烷"分子片断有机结合,以水杨醛和乙二胺为起始原料,经缩合、NaBH4还原制得N,N'-二邻羟苄基乙二胺(2),进而与芳醛类化合物缩合关环,合成了8种N,N'-二(2-羟苄基)取代咪唑烷类化合物(3a～3h). 化合物的结构经1H NMR、IR、MS和元素分析等测试技术进行了表征. 结果表明,水杨醛与乙二胺的缩合反应,可专一性地生成对称双缩席夫碱化合物(1);芳醛上的取代基对缩合关环反应有显著影响,邻、对位吸电基可使芳醛的羰基活化,有利于缩合关环反应的进行,邻、对位供电基可使芳醛的羰基钝化,不利于缩合关环反应进行. 抑菌测试结果表明,质量分数为0.1%时,N,N'-二(2-羟苄基)取代咪唑烷化合物对不同菌株的抑菌活性具有明显的特异性,对白色念珠菌、大肠杆菌的抑菌率达100%.     

N-(4-取代嘧啶-2-基)苄基磺酰脲和苯氧基磺酰脲的3D-QSAR研究

采用比较分子力场分析(CoMFA)方法,对两类单取代嘧啶类似物、6个N-(4-取代嘧啶-2-基)-2-甲氧羰基苄基磺酰脲(1a～1f)和14个N-(4-取代嘧啶-2-基)-2-取代苯氧基磺酰脲(2a～2n)进行三维定量构效关系(3D-QSAR)研究.建立了一个较为可靠的预测模型.结果表明,分子中苯环邻位、嘧啶环形成氢键的N原子处以及嘧啶环4位和6位附近负电荷增加;苯环邻位乙氧基的CH₂CH₃附近选择带正电的原子;苯环邻位乙氧基附近空间体积增加,而嘧啶环4位甲氧基稍远处取代基的立体位阻不超过此位置,将有利于提高活性.最后解释了修饰磺酰脲的除草剂仍具有较高活性的原因.     

新型2-甲氧羰基-5-芳甲亚胺基苯磺酰胺的合成及其生物活性

在微波或超声波辅助下,2-甲氧羰基-5-氨基苯磺酰胺与取代苯甲醛反应合成了8个新型2-甲氧羰基-5-芳甲亚胺基苯磺酰胺(3a ～ 3h),其结构经1H NMR,MS及元素分析表征.生物活性测试结果表明,大部分3具有一定的杀菌活性,其中3b和3f在用量为500 mg·L-1时,对黄瓜菌核病的防治效果高于90％.     

N,N′—二(芳磺酰)磺酰亚胺—S—(2—苯并咪唑)钠、银盐的合成及应用

芳磺酰氯胺钠是一类化学活性很强的物质,由它们参予的许多反应已引起化学工作者浓厚的兴趣。Boberg,Koide和Bruchmann等在这方面做了很多工作。Bruchmann用2—巯基吡啶酮与二分子芳磺酰氯胺钠(氯胺T,氯胺Cl,氯胺N,氯胺B和氯胺M)合成了相应的N,N′—二(芳磺酰)磺酰亚胺—S—(2—吡啶)钠盐化合物。众所周知2—巯基苯并咪     

N2-functionalized blue luminescent guanosines by 2,2'-dipyridylamino and 2-(2'-pyridyl)benzimidazolyl chelate groups and their interactions with Zn(II) ions

The syntheses of new blue luminescent N(2)-modified guanosine derivatives with chromophores p-4,4'-biphenyl-NPh2 (1a), p-4,4'-biphenyl-N(2-py)2 (1b), and p-4,4'-biphenyl-2-(2'-pyridyl)benzimidazolyl (1c), respectively, have been achieved. These new N(2)-guanosines are moderate blue emitters with lambda(max) = 395 nm (1a), 370 nm (1b), and 403 nm (1c) and Phi = 0.13, 0.07, and 0.10 in tetrahydrofuran, respectively. Spectroscopic studies and density-functional theory calculations established that the guanine moiety and the new chromophore in all three molecules are involved in the luminescent process. We have also established that guanosines 1a-1c can interact with metal ions such as Zn(II). The interactions of Zn(II) ions with the three guanosines were examined via absorption, fluorescence, circular dichroism (CD), and NMR spectroscopic analyses. We have found that these guanosines display a distinct fluorescent response toward Zn(II) ions which can be attributed to the presence of the chelate chromophore N(2-py)2 in 1b and 2-py-benzimidazolyl in 1c. For 1a and 1b, the addition of Zn(II) ions causes straight fluorescent quenching while for 1c the addition of Zn(II) ions causes quenching initially, which is followed by a distinct spectral red shift and the intensity enhancement of the new emission peak. NMR and CD studies demonstrated that the Zn(II) ions bind preferentially to the guanine moiety in 1a and 1b but to the 2-(2'-py)benzimidazolyl chelate site in 1c. Moreover, the anion-dependent CD response of 1a-1c toward Zn(II) salts points to the possible involvement of intramolecular hydrogen bonding between the acetate bound to the Zn(II) ion and the hydroxyl groups of the guanosine.     

Modulating the reduction potential of mononuclear cobalt(II) complexes via selective deprotonation of tris[(2-benzimidazolyl)methyl]amine

Remote site deprotonation of the coordinated tripodal ligand, tris((2-benzimidazolyl)methyl)amine, was examined using electronic spectroscopy and electrochemistry techniques. The solid-state structures [CoH(3)1(tba)(NCS)]+ and [CoH(2)1(tba)(NCS)] are reported. These complexes crystallized in the triclinic space group P1 [a = 13.3043(2) A, b = 13.8019(2) A, c = 14.1322(2) A, alpha = 63.6670(10) degrees, beta = 68.0590(10) degrees, gamma = 81.8960 degrees; Z = 2] and the monoclinic space group P2(1)/n [a = 15.3530(9) A, b = 11.0645(6) A, c = 19.1319(10) A, beta = 105.6750(10) degrees; Z = 4], respectively. Preliminary results suggest that selective and reversible deprotonation of coordinated benzimidazolyl ligands can tune the reduction potential of several isostructural cobalt(II) complexes.     

三种新型二苯砜氮杂环蕃N,N’-二对甲苯磺酰基-1,m-二氮杂[m.1]对环蕃-n-砜的合成与表征(m＝8,10,12; n＝15,17,19)

以N,N’-二对甲苯磺酰基-4,4’-二氨基二苯砜与二溴代烷为原料, 高度稀释条件下合成了三种新型有硫原子桥连的氮杂环蕃N,N’-二对甲苯磺酰基-1,8-二氮杂[8.1]对环蕃-15-砜(C); N,N’-二对甲苯磺酰基-1,10-二氮杂[10.1]对环蕃-17-砜(D); N,N’-二对甲苯磺酰基-1,12-二氮杂[12.1]对环蕃-19-砜(E). 提供了三种环蕃化合物的合成方法. 用IR, 1H NMR和元素分析证实了新化合物结构. 分析了化合物D的单晶结构数据, 为环蕃化合物的空间结构研究提供了晶体学依据.     

Blue luminescent 2-(2'-pyridyl)benzimidazole derivative ligands and their orange luminescent mononuclear and polynuclear organoplatinum(II) complexes

Five new 2-(2'-pyridyl)benzimidazole derivative ligands, 1,4-bis[2-(2'-pyridyl)benzimidazolyl]benzene (1,4-bmb), 4,4'-bis[2-(2'-pyridyl)benzimidazolyl]biphenyl (bmbp), 1-bromo-4-[2-(2'-pyridyl)benzimidazolyl]benzene (Brmb), 1,3-bis[2-(2'-pyridyl)benzimidazolyl]benzene (1,3-bmb), and 1,3,5-tris[2-(2'-pyridyl)benzimidazolyl]benzene (tmb), have been synthesized by Ullmann condensation methods. The corresponding mononuclear and polynuclear PtII complexes, Pt2(1,4-bmb)Ph4 (1), Pt2(bmbp)Ph4 (2), Pt(Brmb)Ph2 (3), Pt2(1,3-bmb)Ph4 (4), and Pt3(tmb)Ph6 (5), have been obtained by the reaction of the appropriate ligand with [PtPh2(SMe2)]n. The structures of the free ligands 1,4-bmb, bmbp, and tmb, as well as the complexes 1-3, were determined by single-crystal X-ray diffraction. All ligands display fluorescent emissions in the purple/blue region of the spectrum at ambient temperature and phosphorescent emissions in the blue/green region at 77 K, which are attributable to ligand-centered pi --> pi* transition. No ligand-based emission was observed for the PtII complexes 1-5. All PtII complexes display orange/red emissions at 77 K in a frozen solution or in the solid state, attributable to metal-to-ligand charge transfers (MLCT). Variable-temperature 1H NMR experiments establish that complexes 1, 4, and 5 exist in isomeric forms in solution at ambient temperature due to the hindered rotation of the square PtC2N2 planes in the complexes.     

Synthesis and Crystal Structure of 3,3''-Bis(2-benzimidazolyl)-2,2''-dipyridine with Hydrated Zinc(Ⅱ) Perchlorate

The reaction of Zn(ClO4)2·6H2O with 3,3'-bis(2-benzimidazolyl)-2,2'-dipyridine (L) gave a mononuclear zinc(Ⅱ) complex: [ZnL2](ClO4)2·2DMF·4H2O, which was structurally characterized by EA, IR, UV, 1H NMR, fluorescence spectrum and single-crystal X-ray diffraction. The crystal (C54H54Cl2N14O14Zn, Mr=1259.38) belongs to the monoclinic system, space group C2/c with a=20.874(2), b=14.9953(16), c=20.462(3) (A), β=101.553(2)°, V=6274.8(13) (A)3, Z=4, Dc=1.333 g/cm3, F (000)=2608, μ(MoKα)=0.548 mm-1, R=0.0682 and Wr=0.1931 for 4984 observed reflections with Ⅰ ＞ 2σ(Ⅰ). The Zn(Ⅱ) is four-coordinated in a slightly distorted tetrahedral geometry through four N atoms from four benzimidazole units of two ligands. In the crystal lattice, the [ZnL2]2 cations are linked to each other by extensive intermolecular hydrogen bonds between nitrogen atoms of benzimidazole rings, water and DMF molecules.     

Synthesis and Crystal Structure of 3,3＇-Bis（2-benzimidazolyl）-2,2＇-dipyridine with Hydrated Zinc（Ⅱ） Perchlorate

The reaction of Zn(ClO4)2·6H2O with 3,3'-bis(2-benzimidazolyl)-2,2'-dipyridine (L) gave a mononuclear zinc(II) complex: [ZnL2](ClO4)2·2DMF·4H2O, which was structurally characterized by EA, IR, UV, 1H NMR, fluorescence spectrum and single-crystal X-ray diffraction. The crystal (C54H54Cl2N14O14Zn, Mr = 1259.38) belongs to the monoclinic system, space group C2/c with a = 20.874(2), b = 14.9953(16), c = 20.462(3) , β = 101.553(2)°, V = 6274.8(13) 3, Z = 4, Dc = 1.333 g/cm3, F (000) = 2608, μ(MoKα) = 0.548 mm–1, R = 0.0682 and wR = 0.1931 for 4984 observed reflections with I > 2σ(I). The Zn(II) is four-coordinated in a slightly distorted tetrahedral geometry through four N atoms from four benzimidazole units of two ligands. In the crystal lattice, the [ZnL2]2+ cations are linked to each other by extensive intermolecular hydrogen bonds between nitrogen atoms of benzimidazole rings, water and DMF molecules.     

New phosphorescent polynuclear Cu(I) compounds based on linear and star-shaped 2-(2'-pyridyl)benzimidazolyl derivatives: syntheses, structures, luminescence, and electroluminescence

Four dinuclear and trinuclear Cu(I) complexes that contain 2-(2'-pyridyl)benzimidazolyl derivative ligands including 1,4-bis[2-(2'-pyridyl)benzimidazolyl]benzene (1,4-bmb), 1,3-bis[2-(2'-pyridyl)benzimidazolyl]benzene (1,3-bmb), 1,3,5-tris[2-(2'-pyridyl)benzimidazolyl]benzene (tmb), and 4,4'-bis[2-(2'-pyridyl)benzimidazolyl]biphenyl (bmbp) have been synthesized. The formulas of these complexes are [Cu(2)(1,4-bmb)(PPh(3))(4)][BF(4)](2) (1), [Cu(2)(1,3-bmb)(PPh(3))(4)][BF(4)](2) (2), [Cu(3)(tmb)(PPh(3))(6)][BF(4)](3) (3), and [Cu(2)(bmbp)(PPh(3))(4)][BF(4)](2) (4), respectively. The crystal structures of 2-4 have been determined by single-crystal X-ray diffraction analyses. The Cu(I) ions in the complexes have a distorted tetrahedral geometry. For 3, two structural isomers (syn and anti) resulted from two different orientations of the three 2-(2'-pyridyl)benzimidazolyl chelating units were observed in the crystal lattice. Variable-temperature (1)H NMR experiments established the presence of syn and anti isomers for 1-3 in solution which interconvert at ambient temperature. Complexes 1-4 have a weak MLCT absorption band in the 350-450 nm region and display a yellow-orange emission when irradiated by UV light. One unexpected finding is that the yellow-orange emission of complexes 1-4 has a very long decay lifetime (approximately 200 micros) at 77 K. An electroluminescent (EL) device using 4 as the emitter and PVK as the host was fabricated. However, the long decay lifetime of the copper complexes may limit their applications as phosphorescent emitters in EL devices.     

Polyfluorinated Tris(pyrazolyl)borates. Syntheses and Spectroscopic and Structural Characterization of Group 1 and Group 11 Metal Complexes of [HB(3,5-(CF(3))(2)Pz)(3)](-) and [HB(3-(CF(3))Pz)(3)](-)

The fluorinated tris(pyrazolyl)borate ligands [HB(3,5-(CF(3))(2)Pz)(3)](-) and [HB(3-(CF(3))Pz)(3)](-) (where Pz = pyrazolyl) have been synthesized as their sodium salts from the corresponding pyrazoles and NaBH(4) in high yield. These sodium complexes and the related [HB(3,5-(CF(3))(2)Pz)(3)]K(DMAC) were used as ligand transfer agents in the preparation of the copper and silver complexes [HB(3,5-(CF(3))(2)Pz)(3)]Cu(DMAC), [HB(3,5-(CF(3))(2)Pz)(3)]CuPPh(3), [HB(3,5-(CF(3))(2)Pz)(3)]AgPPh(3), and [HB(3-(CF(3))Pz)(3)]AgPPh(3). Metal complexes of the fluorinated [HB(3,5-(CF(3))(2)Pz)(3)](-) ligand have highly electrophilic metal sites relative to their hydrocarbon analogs. This is evident from the formation of stable adducts with neutral oxygen donors such as H(2)O, dimethylacetamide, or thf. Furthermore, the metal compounds derived from fluorinated ligands show fairly long-range coupling between fluorines of the trifluoromethyl groups and the hydrogen, silver, or phosphorus. The solid state structures show that the fluorines are in close proximity to these nuclei, thus suggesting a possible through-space coupling mechanism. Crystal structures of the sodium adducts exhibit significant metal-fluorine interactions. The treatment of [HB(3,5-(CF(3))(2)Pz)(3)]Na(H(2)O) with Et(4)NBr led to [Et(4)N][HB(3,5-(CF(3))(2)Pz)(3)], which contains a well-separated [Et(4)N](+) cation and the [HB(3,5-(CF(3))(2)Pz)(3)](-) anion in the solid state. Crystal data with Mo Kalpha (lambda = 0.710 73 ?) at 193 K: [HB(3,5-(CF(3))(2)Pz)(3)]Na(H(2)O), C(15)H(6)BF(18)N(6)NaO, a = 7.992(2) ?, b = 15.049(2) ?, c = 9.934(2) ?, beta = 101.16(2) degrees, monoclinic, P2(1)/m, Z = 2; [{HB(3-(CF(3))Pz)(3)}Na(thf)](2), C(32)H(30)B(2)F(18)N(12)Na(2)O(2), a = 9.063(3) ?, b = 10.183(2) ?, c = 12.129(2) ?, alpha = 94.61(1) degrees, beta = 101.16(2) degrees, gamma = 95.66(2) degrees, triclinic, &Pmacr;1, Z = 1; [HB(3,5-(CF(3))(2)Pz)(3)]Cu(DMAC), C(19)H(13)BCuF(18)N(7)O, a = 15.124(4) ?, b = 8.833(2) ?, c = 21.637(6) ?, beta = 105.291(14) degrees, monoclinic, P2(1)/n, Z = 4; [HB(3,5-(CF(3))(2)Pz)(3)]CuPPh(3), C(33)H(19)BCuF(18)N(6)P, a = 9.1671(8) ?, b = 14.908(2) ?, c = 26.764(3) ?, beta = 94.891(1) degrees, monoclinic, P2(1)/c, Z = 4; [HB(3,5-(CF(3))(2)Pz)(3)]AgPPh(3).0.5C(6)H(14), C(36)H(26)AgBF(18)N(6)P, a = 13.929(2) ?, b = 16.498(2) ?, c = 18.752(2) ?, beta = 111.439(6) degrees, monoclinic, P2(1)/c, Z = 4; [Et(4)N][HB(3,5-(CF(3))(2)Pz)(3)], C(23)H(24)BF(18)N(7), a = 10.155(2) ?, b = 18.580(4) ?, c = 16.875(5) ?, beta = 99.01(2) degrees, monoclinic, P2(1)/n, Z = 4.     

1,1-二(2-苯并咪唑基)-2-苯基乙烯衍生物荧光受体的合成与阳离子识别

合成了3种新型1,1-二(2-苯并咪唑基)-2-苯基乙烯衍生物——1,1-二(2-苯并咪唑基)-2(4-氰基苯基)乙烯(1)、1,1-二(2-苯并咪唑基)-2(4-甲氧羰基苯基)乙烯(2)和1,1-二(2-苯并咪唑基)-4-苯基-1,3-丁二烯(3),通过核磁共振氢谱和碳谱(1H、13C NMR)、质谱(MS)对它们进行了结构表征。用紫外可见吸收光谱(UV-V is)和荧光发射光谱测定了该阳离子受体与不同金属离子(Zn2 、Cd2 、Hg2 和Cu2 )的络合选择性。结果表明:该荧光受体对Zn2 、Cd2 、Hg2 和Cu2 均具有较高的选择性和荧光响应。